Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: The HEAL study

Breast Cancer Research and Treatment

Volumn 129, Issue 2, 2011, Pages 485-494

  Villaseñor, Adriana ^a   Ambs, Anita ^b   Ballard Barbash, Rachel ^b   Baumgartner, Kathy B ^c   McTiernan, Anne ^a   Ulrich, Cornelia M ^a   Neuhouser, Marian L ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Breast cancer; C reactive protein; Dietary fiber; Inflammation; Serum amyloid A

Indexed keywords

ALPHA TOCOPHEROL; C REACTIVE PROTEIN; SERUM AMYLOID A;

ADULT; AFRICAN AMERICAN; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CANCER SURVIVOR; CAUCASIAN; CONSULTATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY FIBER; DIETARY INTAKE; EDUCATIONAL STATUS; FEMALE; HISPANIC; HUMAN; HYPERTENSION; INFLAMMATION; INTERVIEW; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE;

AFRICAN AMERICANS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; C-REACTIVE PROTEIN; DIETARY FIBER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LINEAR MODELS; LOGISTIC MODELS; ODDS RATIO; SERUM AMYLOID A PROTEIN; SURVIVORS; TREATMENT OUTCOME; UNITED STATES;

EID: 80052620314     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1474-6     Document Type: Article

References (62)

1. MK Rutter, et al. 2004 C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study Circulation 110 4 380 385 15262834 10.1161/01.CIR.0000136581.59584.0E 1:CAS:528:DC%2BD2cXlslGmt74%3D (Pubitemid 38993845)
2. N Sattar, et al. 2003 Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study Circulation 108 4 414 419 12860911 10.1161/01.CIR.0000080897.52664.94 1:CAS:528:DC%2BD3sXlsFOjt7s%3D See comment (Pubitemid 36935533)
3. F Balkwill A Mantovani 2001 Inflammation and cancer: back to Virchow? Lancet 357 9255 539 545 11229684 10.1016/S0140-6736(00)04046-0 1:CAS:528:DC%2BD3MXhsVKltb0%3D See comment (Pubitemid 32173595)
4. LM Coussens Z Werb 2002 Inflammation and cancer Nature 420 6917 860 867 12490959 10.1038/nature01322 1:CAS:528:DC%2BD38XpsFygtb4%3D See comment (Pubitemid 36019639)
5. J Condeelis JW Pollard 2006 Macrophages: obligate partners for tumor cell migration, invasion, and metastasis Cell 124 2 263 266 16439202 10.1016/j.cell.2006.01.007 1:CAS:528:DC%2BD28Xht1KktLo%3D (Pubitemid 43121975)
6. M Egeblad LE Littlepage Z Werb 2005 The fibroblastic coconspirator in cancer progression Cold Spring Harbor Symp Quant Biol 70 383 388 16869775 10.1101/sqb.2005.70.007 1:CAS:528:DC%2BD28XoslCgsb0%3D (Pubitemid 44124893)
7. M Egeblad Z Werb 2002 New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 3 161 174 11990853 10.1038/nrc745 1:CAS:528:DC%2BD38Xis1KktL8%3D (Pubitemid 37328786)
8. D Wang RN Dubois 2006 Prostaglandins and cancer Gut 55 1 115 122 16118353 10.1136/gut.2004.047100 1:CAS:528:DC%2BD28Xnt1yquw%3D%3D (Pubitemid 41820645)
9. A Zlotnik 2006 Chemokines and cancer Int J Cancer 119 9 2026 2029 16671092 10.1002/ijc.22024 1:CAS:528:DC%2BD28XhtVSks7bE (Pubitemid 44423657)
10. M Karin FR Greten 2005 NF-kappaB: linking inflammation and immunity to cancer development and progression Nat Rev Immunol 5 10 749 759 16175180 10.1038/nri1703 1:CAS:528:DC%2BD2MXhtVGrurvL (Pubitemid 41400849)
11. TA Pearson, et al. 2003 Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 3 499 511 12551878 10.1161/01.CIR.0000052939.59093.45 See comment (Pubitemid 36158056)
12. M Hara, et al. 2007 Preoperative serum C-reactive protein level in non-small cell lung cancer Anticancer Res 27 4C 3001 3004 17695486 1:CAS:528:DC%2BD2sXpvFChtbg%3D (Pubitemid 47228036)
13. K Heikkila S Ebrahim DA Lawlor 2007 A systematic review of the association between circulating concentrations of C reactive protein and cancer J Epidemiol Community Health 61 9 824 833 17699539 10.1136/jech.2006.051292 (Pubitemid 47311721)
14. M Bolayirli, et al. 2007 C-reactive protein as an acute phase protein in cancer patients Med Oncol 24 3 338 344 17873311 10.1007/s12032-007-0012-1 1:CAS:528:DC%2BD2sXhtFaht7vJ (Pubitemid 350135957)
15. MA McSorley, et al. 2007 C-reactive protein concentrations and subsequent ovarian cancer risk Obstet Gynecol 109 4 933 941 17400857 10.1097/01.AOG. 0000257126.68803.03 1:CAS:528:DC%2BD2sXkvVOls7c%3D (Pubitemid 46559083)
16. D Trichopoulos, et al. 2006 Plasma C-reactive protein and risk of cancer: a prospective study from Greece Cancer Epidemiol Biomarkers Prev 15 2 381 384 16492932 10.1158/1055-9965.EPI-05-0626 1:CAS:528:DC%2BD28Xhs1WrtLk%3D (Pubitemid 43348407)
17. J Plutzky 2001 Inflammatory pathways in atherosclerosis and acute coronary syndromes Am J Cardiol 88 8A 10K 15K 11694213 10.1016/S0002-9149(01) 01924-5 1:CAS:528:DC%2BD3MXnvFCqsrg%3D (Pubitemid 33016744)
18. DR Cottam, et al. 2004 The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss Obes Surg 14 5 589 600 15186624 10.1381/096089204323093345 (Pubitemid 38716577)
19. DE King, et al. 2005 Fiber and C-reactive protein in diabetes, hypertension, and obesity Diabetes Care 28 6 1487 1489 15920074 10.2337/diacare.28.6.1487 1:CAS:528:DC%2BD2MXlsFyhtb4%3D (Pubitemid 40756719)
20. W Koenig, et al. 1999 C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 Circulation 99 2 237 242 9892589 1:STN:280:DyaK1M7htVOhtQ%3D%3D (Pubitemid 29056365)
21. CJ North CS Venter JC Jerling 2009 The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease Eur J Clin Nutr 63 8 921 933 19223918 10.1038/ejcn.2009.8 1:CAS:528: DC%2BD1MXps1Wmu7s%3D
22. MA Pereira JJ Pins 2000 Dietary fiber and cardiovascular disease: experimental and epidemiologic advances Curr Atheroscler Rep 2 6 494 502 11122784 10.1007/s11883-000-0049-5 1:STN:280:DC%2BD3Mzptlahsw%3D%3D
23. O Kanauchi, et al. 2003 Modification of intestinal flora in the treatment of inflammatory bowel disease Curr Pharm Des 9 4 333 346 12570821 10.2174/1381612033391883 1:CAS:528:DC%2BD3sXksl2msg%3D%3D (Pubitemid 36131727)
24. WD Rosamond 2002 Dietary fiber and prevention of cardiovascular disease J Am Coll Cardiol 39 1 57 59 11755287 10.1016/S0735-1097(01)01685-0 See comment (Pubitemid 34059861)
25. JL Slavin 2000 Mechanisms for the impact of whole grain foods on cancer risk J Am Coll Nutr 19 3 Suppl 300S 307S 10875601 1:CAS:528:DC%2BD3cXksVGgt7Y%3D (Pubitemid 30399585)
26. L Yin G Laevsky C Giardina 2001 Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity J Biol Chem 276 48 44641 44646 11572859 10.1074/jbc.M105170200 1:CAS:528:DC%2BD3MXovFegt7o%3D
27. Y Ma, et al. 2008 Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study Nutrition 24 10 941 949 18562168 10.1016/j.nut.2008.04.005 1:CAS:528: DC%2BD1cXhtVyms7nP
28. DE King, et al. 2007 Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level Arch Intern Med 167 502 506 17353499 10.1001/archinte.167.5.502 1:CAS:528:DC%2BD2sXktVCjurc%3D (Pubitemid 46425664)
29. DE King BM Egan ME Geesey 2003 Relation of dietary fat and fiber to elevation of C-reactive protein Am J Cardiol 92 11 1335 1339 14636916 10.1016/j.amjcard.2003.08.020 1:CAS:528:DC%2BD3sXptVWntr8%3D Erratum appears in Am J Cardiol. 2004 Mar 15;93(6):812 (Pubitemid 37431147)
30. Y Ma, et al. 2006 Association between dietary fiber and serum C-reactive protein Am J Clin Nutr 83 4 760 766 16600925 1:CAS:528:DC%2BD28XjvFWis7c%3D (Pubitemid 44713137)
31. UA Ajani ES Ford AH Mokdad 2004 Dietary fiber and C-reactive protein: findings from national health and nutrition examination survey data J Nutr 134 5 1181 1185 15113967 1:CAS:528:DC%2BD2cXjvFGqu7o%3D (Pubitemid 38619960)
32. BL Pierce, et al. 2009 Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients J Clin Oncol 27 21 3437 3444 19470939 10.1200/JCO.2008.18.9068 1:CAS:528:DC%2BD1MXhtVSqtLvE
33. American Cancer Society (2008) Cancer Facts & Figures 2008. Atlanta, American Cancer Society
34. I Romieu, et al. 2004 Carbohydrates and the risk of breast cancer among Mexican women Cancer Epidemiol Biomarkers Prev 13 8 1283 1289 15298947 1:CAS:528:DC%2BD2cXmtleksr4%3D (Pubitemid 39071550)
35. ML Irwin, et al. 2003 Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study Cancer 97 7 1746 1757 12655532 10.1002/cncr.11227 (Pubitemid 36350718)
36. ML Irwin, et al. 2004 Physical activity levels among breast cancer survivors Med Sci Sports Exerc 36 9 1484 1491 15354027 (Pubitemid 39202614)
37. A McTiernan, et al. 2003 Adiposity and sex hormones in postmenopausal breast cancer survivors J Clin Oncol 21 10 1961 1966 12743149 10.1200/JCO.2003.07.057 1:CAS:528:DC%2BD2cXptlCksbo%3D (Pubitemid 46606384)
38. RE Patterson, et al. 1999 Measurement characteristics of the Women's Health Initiative food frequency questionnaire Ann Epidemiol 9 3 178 187 10192650 10.1016/S1047-2797(98)00055-6 1:STN:280:DyaK1M3gs1ylug%3D%3D (Pubitemid 29144458)
39. TB Ledue, et al. 1998 Evaluation of proficiency survey results for serum immunoglobulins following the introduction of a new international reference material for human serum proteins Clin Chem 44 4 878 879 9554502 1:CAS:528:DyaK1cXisFSit7o%3D (Pubitemid 28176034)
40. N Rifai RP Tracy PM Ridker 1999 Clinical efficacy of an automated high-sensitivity C-reactive protein assay Clin Chem 45 12 2136 2141 10585345 1:CAS:528:DyaK1MXnvF2mu74%3D
41. MH Wener PR Daum GM McQuillan 2000 The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration J Rheumatol 27 10 2351 2359 11036829 1:CAS:528:DC%2BD3cXnsFCqs78%3D
42. ES Ford 1999 Body mass index, diabetes, and C-reactive protein among U.S. adults Diabetes Care 22 12 1971 1977 10587828 10.2337/diacare.22.12.1971 1:STN:280:DC%2BD3c%2FlsFWnsg%3D%3D See comment (Pubitemid 30433974)
43. M Visser, et al. 1999 Elevated C-reactive protein levels in overweight and obese adults JAMA 282 22 2131 2135 10591334 10.1001/jama.282.22.2131 1:CAS:528:DC%2BD3cXhvV2hsg%3D%3D See comment
44. RP Tracy, et al. 1997 Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects Arterioscler Thromb Vasc Biol 17 10 2167 2176 9351386 10.1161/01.ATV.17.10.2167 1:STN:280:DyaK1c%2Fht1Oguw%3D%3D (Pubitemid 28057118)
45. K Prasad 2006 C-reactive protein (CRP)-lowering agents Cardiovasc Drug Rev 24 1 33 50 16939632 10.1111/j.1527-3466.2006.00033.x 1:CAS:528: DC%2BD2sXhtlWjsrbM (Pubitemid 46722293)
46. DE King, et al. 2003 Inflammatory markers and exercise: differences related to exercise type Med Sci Sports Exerc 35 4 575 581 12673139 10.1249/01.MSS.0000058440.28108.CC (Pubitemid 36417846)
47. BL Pierce, et al. 2008 Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors Breast Cancer Res Treat 114 1 155 167 18401703 10.1007/s10549-008-9985-5
48. S Kinlay AP Selwyn 2003 Effects of statins on inflammation in patients with acute and chronic coronary syndromes Am J Cardiol 91 4A 9B 13B 12615293 10.1016/S0002-9149(02)03268-X 1:CAS:528:DC%2BD3sXisVWnt7Y%3D (Pubitemid 36263243)
49. HE Bays, et al. 2002 Effects of simvastatin on C-reactive protein in mixed hyperlipidemic and hypertriglyceridemic patients Am J Cardiol 90 9 942 946 12398959 10.1016/S0002-9149(02)02658-9 1:CAS:528:DC%2BD38XotVeqtL4%3D (Pubitemid 35232616)
50. SM Haffner, et al. 2002 Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus Circulation 106 6 679 684 12163427 10.1161/01.CIR.0000025403. 20953.23 1:CAS:528:DC%2BD38XmvFSmsLw%3D See comment (Pubitemid 34851926)
51. AM Al Murri, et al. 2007 Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer Br J Cancer 96 6 891 895 17375036 10.1038/sj.bjc.6603682 1:CAS:528:DC%2BD2sXjt1Srsb0%3D (Pubitemid 46452298)
52. Cohen J et al (2003) Applied multiple regression/correlation analysis for the behavioral sciences, 3rd edn. Erlbaum, Hillsdale, p 425
53. M Galisteo J Duarte A Zarzuelo 2008 Effects of dietary fibers on disturbances clustered in the metabolic syndrome J Nutr Biochem 19 2 71 84 17618108 10.1016/j.jnutbio.2007.02.009 1:CAS:528:DC%2BD1cXivFarsw%3D%3D
54. A Basu S Devaraj I Jialal 2006 Dietary factors that promote or retard inflammation Arterioscler Thromb Vasc Biol 26 5 995 1001 16484595 10.1161/01.ATV.0000214295.86079.d1 1:CAS:528:DC%2BD28XjsVers7w%3D (Pubitemid 43732103)
55. H Sell, et al. 2010 Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery J Clin Endocrinol Metab 95 6 2892 2896 20375212 10.1210/jc.2009-2374 1:CAS:528:DC%2BC3cXnvVaktr0%3D
56. NM Delzenne PD Cani 2005 A place for dietary fibre in the management of the metabolic syndrome Curr Opin Clin Nutr Metab Care 8 6 636 640 16205465 10.1097/01.mco.0000171124.06408.71 (Pubitemid 41586005)
57. PD Cani, et al. 2009 Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal Am J Clin Nutr 90 5 1236 1243 19776140 10.3945/ajcn.2009.28095 1:CAS:528:DC%2BD1MXhtlentb7J
58. M Vijay-Kumar, et al. 2010 Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 Science 328 5975 228 231 20203013 10.1126/science.1179721 1:CAS:528:DC%2BC3cXkt1Cgt7o%3D
59. S Aggarwal, et al. 2010 Prostaglandin E2 and cysteinyl leukotriene concentrations in sputum: association with asthma severity and eosinophilic inflammation Clin Exp Allergy 40 1 85 93 19895589 1:CAS:528:DC%2BC3cXht1KisLw%3D
60. DR Jacobs Jr LF Andersen R Blomhoff 2007 Whole-grain consumption is associated with a reduced risk of noncardiovascular, noncancer death attributed to inflammatory diseases in the Iowa Women's Health Study Am J Clin Nutr 85 6 1606 1614 17556700 1:CAS:528:DC%2BD2sXmvVWqur4%3D (Pubitemid 46890431)
61. L Qi, et al. 2006 Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women Diabetes Care 29 2 207 211 16443861 10.2337/diacare.29.02.06.dc05-1903 1:CAS:528:DC%2BD2sXhtFyls7vE (Pubitemid 44106493)
62. ML Neuhouser, et al. 2008 Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative Am J Epidemiol 167 10 1247 1259 18344516 10.1093/aje/kwn026 (Pubitemid 351670635)